NextCure Inc. (NXTC) - 5i Research

NextCure Inc. (NXTC $11.10)
- $11.10 Cap: $61M
- View NXTC Profile
- View Questions on NXTC

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $384.32)
- $384.32 P/E (TTM): 28.28X Cap: $198.05B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $785.51)
- $785.51 P/E (TTM): 18.53X Cap: $83.04B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $477.92)
- $477.92 P/E (TTM): 32.9X Cap: $121.25B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,373.57)
- $1,373.57 P/E (TTM): 34.7X Cap: $28.24B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $6.52)
- $6.52 Cap: $507M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $11.10)
- $11.10 Cap: $61M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

NextCure Inc. (NXTC $11.10)
- $11.10 Cap: $61M
- View NXTC Profile
- View Questions on NXTC

Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.

Read Answer Asked by Vinod on November 15, 2019